AttNIRS: Attentional Focus and Prefrontal Cortical Activation

Sponsor
Centre Hospitalier Régional d'Orléans (Other)
Overall Status
Completed
CT.gov ID
NCT04757844
Collaborator
(none)
30
1
1
2.2
13.8

Study Details

Study Description

Brief Summary

Attention may influence the motor performance and frontal activity. This study will examine the effect of different attentional focus : internal, external and divided attention (dual task) on prefrontal cortical activation (fNIRS) and on gait performance. Thirty young healthy voluntary adults will participate in this study.

Condition or Disease Intervention/Treatment Phase
  • Device: Functional Near-Infrared Spectroscopy (fNIRS)
N/A

Detailed Description

The subjects will be guided to walk at a normal pace while maintaining the required attentional focus. They will walk on 30 m five times in each of the four different focus conditions :1) no instructions about the attentional focus 2) internal focus on their feet movements, 3) external focus on two lines drawn on the floor, 4) divided attention (walking while performing an arithmetic task). A fNIRS system will be used for the prefrontal cortex activation evaluation and FeetMe soles for gait analyses.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
The Effects of Different Attentional Focus During Walking on Prefrontal Cortical Activation in Young Healthy Adults
Actual Study Start Date :
Feb 12, 2021
Actual Primary Completion Date :
Apr 19, 2021
Actual Study Completion Date :
Apr 19, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Young healthy voluntary adults

30 young healthy voluntary adults

Device: Functional Near-Infrared Spectroscopy (fNIRS)
The hemodynamic response in prefrontal cortex will be measured using an Octamon+ system (Artinis). Eight emission and two detector probes will be arranged on the participant's forehead.

Outcome Measures

Primary Outcome Measures

  1. Effects of different attentional conditions on hemodynamic response in prefrontal cortex [Baseline]

    Oxyhemoglobin variations in prefrontal cortex measured with fNIRS

  2. Effects of different attentional conditions on hemodynamic response in prefrontal cortex [Baseline]

    Deoxyhemoglobin variations in prefrontal cortex measured with fNIRS

Secondary Outcome Measures

  1. Effects of speed on gait. [Baseline]

    Gait parameters will be measured with connected soles FeetMe ® : speed

  2. Effects of cadence on gait. [Baseline]

    Gait parameters will be measured with connected soles FeetMe ® : cadence

  3. Effects of stride length on gait. [Baseline]

    Gait parameters will be measured with connected soles FeetMe ® : stride length

  4. Effects of double support time on gait. [Baseline]

    Gait parameters will be measured with connected soles FeetMe ® : double support time

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Man or woman

  • 18 -30 years old

  • Informed consent obtained

  • Free from any neurological, cardiologic, rheumatologic disorders.

Exclusion Criteria:
  • Assisted walker.

  • Disorders affecting gait.

  • Concomitant medication likely to interfere with the results.

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHR Orléans Orléans France 45067

Sponsors and Collaborators

  • Centre Hospitalier Régional d'Orléans

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Centre Hospitalier Régional d'Orléans
ClinicalTrials.gov Identifier:
NCT04757844
Other Study ID Numbers:
  • CHRO 2020-22
First Posted:
Feb 17, 2021
Last Update Posted:
Sep 1, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier Régional d'Orléans

Study Results

No Results Posted as of Sep 1, 2021